{"basic_info": {"ticker": "300110", "exchange": "XSHE", "bloomberg_ticker": "300110 CH Equity", "name": "HUAREN PHARMACEUTICAL CO L-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "华仁药业", "period": "2020", "market_value": 5544579072, "total_income": 1616318827, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1451970992, "business_income_over_total_income": 0.8983196679673396}, {"shariah_compliance": "unknown", "income": 164347832, "business_income_over_total_income": 0.10168033017659084}], "details": [{"business_activity_cn": "基础输液", "business_activity_en": "Foundation infusion", "income": 555288427, "business_income_over_total_income": 0.34355129552667146, "shariah_compliance": "compliant"}, {"business_activity_cn": "治疗输液", "business_activity_en": "Infusion therapy", "income": 90937228, "business_income_over_total_income": 0.056261936989737235, "shariah_compliance": "compliant"}, {"business_activity_cn": "腹透液", "business_activity_en": "Dialysate", "income": 227342746, "business_income_over_total_income": 0.14065464201884223, "shariah_compliance": "compliant"}, {"business_activity_cn": "医药原料", "business_activity_en": "Pharmaceutical raw materials", "income": 351222792, "business_income_over_total_income": 0.21729796506292876, "shariah_compliance": "compliant"}, {"business_activity_cn": "医疗器械", "business_activity_en": "medical instruments", "income": 227179799, "business_income_over_total_income": 0.14055382836916, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 164347832, "business_income_over_total_income": 0.10168033017659084, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.2033692995772283, "shariah_compliance": "non-compliant", "amount_over_market_value": 0.2033692995772283}]}